Nonacog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Patients with Moderately Severe or Severe Hemophilia B in India

PURPOSE: Hemophilia B is an X-linked congenital bleeding disorder caused by a deficiency of coagulation factor IX (FIX) clotting activity. This study evaluated safety and efficacy of nonacog alfa, a recombinant human blood coagulation FIX replacement product, in males aged 12–65 years with hemophili...

Descripción completa

Detalles Bibliográficos
Autores principales: Choraria, Nirmalkumar, Rangarajan, Savita, John, M. Joseph, Apte, Shashikant, Gupta, Pritam, Pai, Seema, Chand, Rohit, Parvatini, Shyam, Ramakanth, G. S. H., Rupon, Jeremy, Chhabra, Amit, Muley, Hitesh Bhaskarrao, Simoneau, Damien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542435/
https://www.ncbi.nlm.nih.gov/pubmed/37790744
http://dx.doi.org/10.1007/s12288-022-01588-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542435/
https://www.ncbi.nlm.nih.gov/pubmed/37790744
http://dx.doi.org/10.1007/s12288-022-01588-0

Ejemplares similares